Cipla has been committed to improving the lives of millions of people suffering from lung disease for over six decades. Established in 1935 with the mission of "Caring for Life," Cipla operates in over 80 countries with 46 manufacturing sites worldwide. Cipla is a respiratory leader, ranking #2 in inhaler sales globally and in the top 3 for US generic respiratory sales*.
In alignment with Cipla’s commitment to respiratory health, we have contributed to the American Lung Association by sponsoring the 2024 LUNG FORCE Walk New York City. We are proud to support the ALA’s mission of improving lung health and preventing lung disease through education, advocacy, and research.
For more information about Cipla and its commitment to respiratory health, please visit Cipla’s US website at www.ciplausa.com